KMTS vs LMAT: stock comparison and AI forecast
Kestra Medical Technologies, Ltd. (KMTS) and Lemaitre Vascular Inc (LMAT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KMTS Kestra Medical Technologies, Ltd.
- Market Cap
- $1.70B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
LMAT Lemaitre Vascular Inc
- Market Cap
- $1.91B
- P/E Ratio
- 32.6x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- LMAT is 1.1 times larger than KMTS by market capitalization ($1.91B against $1.70B).
- LMAT turns 23.5% of its revenue into net income, against -140.4% for KMTS.
- KMTS carries 0.56 times debt per unit of equity, against 0.52 times for LMAT.
- LMAT yields 1.14% in dividends; KMTS pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KMTS | LMAT |
|---|---|---|
| Market Cap | $1.70B | $1.91B |
| P/E Ratio | – | 32.61x |
| P/B Ratio | 7.64x | 4.42x |
| Dividend Yield | – | 1.14% |
| EPS | $-2.68 | $2.56 |
| Book Value/Share | $3.73 | $18.90 |
| Revenue/Share | $1.79 | $11.78 |
| FCF/Share | $-2.06 | $2.93 |
Profitability & Margins
| Metric | KMTS | LMAT |
|---|---|---|
| ROE | -67.4% | 14.7% |
| ROA | -43.1% | 9.7% |
| ROIC | -48.0% | 12.0% |
| Gross Margin | 53.9% | 72.0% |
| Operating Margin | -134.5% | 27.7% |
| Net Margin | -140.4% | 23.5% |
| EBT Margin | -140.1% | 30.4% |
| Tax Rate | -0.2% | 22.6% |
Financial Health
| Metric | KMTS | LMAT |
|---|---|---|
| Current Ratio | 4.69x | 14.60x |
| Quick Ratio | – | 13.63x |
| D/E Ratio | 0.56x | 0.52x |
| Financial Leverage | 1.56x | 1.52x |
| Interest Coverage | -34.3x | 13.6x |
| Working Capital | $178M | $471M |
Cash Flow
| Metric | KMTS | LMAT |
|---|---|---|
| Operating Cash Flow | -$88M | $76M |
| Free Cash Flow | -$123M | $67M |
| Capital Spending | -$35M | -$9M |
| OCF Growth YoY | – | 4.0% |
| FCF Growth YoY | – | 1.2% |
| FCF/Sales | -115.0% | 24.9% |
| CapEx/Sales | 32.9% | 3.4% |
Operational Efficiency
| Metric | KMTS | LMAT |
|---|---|---|
| Asset Turnover | 0.31x | 0.41x |
| Receivables Turnover | 6.9x | 7.5x |
| Inventory Turnover | – | 2.2x |
| Fixed Assets Turnover | 1.7x | 8.8x |
| Days Sales Outstanding | 53 days | 49 days |
| Days Inventory | – | 163 days |
| Payables Period | 193 days | 20 days |
| Cash Conversion Cycle | – | 191 days |
Income Statement
| Metric | KMTS | LMAT |
|---|---|---|
| Total Revenue | $107M | $269M |
| Operating Income | -$144M | $75M |
| Net Income | -$150M | $63M |
| R&D Expense | $22M | $17M |
| SG&A Expense | $179M | $119M |
| Cost of Goods Sold | $49M | $75M |
Dividend & Shareholder Information
| Metric | KMTS | LMAT |
|---|---|---|
| Dividends Per Share | – | $0.95 |
| Payout Ratio | – | 37.1% |
| Shares Outstanding | 60M | 23M |
| Net Income Growth | – | 18.8% |
| EPS Growth | – | -8.2% |
KMTS vs LMAT: stock comparison and AI forecast
Which is bigger, KMTS or LMAT?
LMAT is 1.1 times larger than KMTS by market capitalization ($1.91B against $1.70B).
Which one does Intratio's AI model rank higher, KMTS or LMAT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.